Clinical implications of a molecular genetic classification of monogenic β-cell diabetes
The DOI matches its Crossref record; 91 of the 91 references it cites were found in a registry or an index.
Abstract
Monogenic diabetes resulting from mutations that primarily reduce beta-cell function accounts for 1-2% of diabetes cases, although it is often misdiagnosed as either type 1 or type 2 diabetes. Knowledge of the genetic etiology of diabetes enables more-appropriate treatment, better prediction of disease progression, screening of family members and genetic counseling. We propose that the old clinical classifications of maturity-onset diabetes of the young and neonatal diabetes are obsolete and that specific genetic etiologies should be sought in four broad clinical situations because of their specific treatment implications. Firstly, diabetes diagnosed before 6 months of age frequently results from mutation of genes that encode Kir6.2 (ATP-sensitive inward rectifier potassium channel) or sulfonylurea receptor 1 subunits of an ATP-sensitive potassium channel, and improved glycemic control can be achieved by treatment with high-dose sulfonylureas rather than insulin. Secondly, patients with stable, mild fasting hyperglycemia detected particularly when they are young could have a glucokinase mutation and might not require specific treatment. Thirdly, individuals with familial, young-onset diabetes that does not fit with either type 1 or type 2 diabetes might have mutations in the transcription factors HNF-1alpha (hepatocyte nuclear factor 1-alpha) or HNF-4alpha, and can be treated with low-dose sulfonylureas. Finally, extrapancreatic features, such as renal disease (caused by muta…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, an exception is the mutational analyses established for classification of diabetes in the neonate (381-384) as well as in young individuals with a dominant family history of diabetes, often referred to as maturityonset diabetes of the young (MODY) (384,385) (Table 8).”
From Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus (2023) · cites this paper as [383]
In the citing paper
“Infants with neonatal diabetes due to a mutation in the KCNJ11 (potassium inwardly-rectifying channel, subfamily J, member 11; also known as KIR6.2) gene may be treated with sulfonylurea rather than with insulin (258,259).”
From Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus (2011) · cites this paper as [258]
In the citing paper
“Genetic markers are currently of limited clinical value in evaluating and managing patients with diabetes; however, mutational analysis is rapidly emerging for classifying diabetes in the neonate (258-260) and in young patients with a dominant family history of diabetes, often referred to as “maturityonset diabetes of the young” (MODY) (261).”
From Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus (2011) · cites this paper as [258]
Citations
Cites
Bennett, C. L., Christie, J., Ramsdell, F., Brunkow, M. E., Ferguson, P. J., Whitesell, L., Kelly, T. E., Saulsbury, F. T., Chance, P. F., & Ochs, H. D. (2001) · Nature Genetics · doi:10.1038/83713 · Cited by 3,402
Goto, Y.-I., Nonaka, I., & Horai, S. (1990) · Nature · doi:10.1038/348651a0 · Cited by 2,070
Wildin, R. S., Ramsdell, F., Peake, J., Faravelli, F., Casanova, J.-L., Buist, N., Levy-Lahad, E., Mazzella, M., Goulet, O., Perroni, L., et al. (2001) · Nature Genetics · doi:10.1038/83707 · Cited by 1,922
Gloyn, A. L., Pearson, E. R., Antcliff, J. F., Proks, P., Bruining, G. J., Slingerland, A. S., Howard, N., Srinivasan, S., Silva, J. M. C. L., Molnes, J., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032922 · Cited by 1,137
Self-citationSwitching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations
Pearson, E. R., Flechtner, I., Njølstad, P. R., Malecki, M. T., Flanagan, S. E., Larkin, B., Ashcroft, F. M., Klimes, I., Codner, E., Iotova, V., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa061759 · Cited by 988
Self-citationChatila, T. A., Blaeser, F., Ho, N., Lederman, H. M., Voulgaropoulos, C., Helms, C., & Bowcock, A. M. (2000) · Journal of Clinical Investigation · doi:10.1172/jci11679 · Cited by 940
A comparison of glyburide and insulin in women with gestational diabetes mellitus
Langer, O., Conway, D. L., Berkus, M. D., Xenakis, E. M.-J., & Gonzales, O. (2000) · New England Journal of Medicine · doi:10.1056/nejm200010193431601 · Cited by 924 · cited 1×
“Currently, insulin remains the most common treatment during pregnancy for this patient group, but further studies are required to validate the safety and efficacy of sulfonylureas such as glibenclamide (also known as glyburide) that have least permeability through the placenta and have been used in gestational diabetes”
BackgroundEarly-onset type-ll diabetes mellitus (MODY4) linked to IPF1
Staffers, D. A., Ferrer, J., Clarke, W. L., & Habener, J. F. (1997) · Nature Genetics · doi:10.1038/ng1097-138 · Cited by 882
Delépine, M., Nicolino, M., Barrett, T., Golamaully, M., Mark Lathrop, G., & Julier, C. (2000) · Nature Genetics · doi:10.1038/78085 · Cited by 813
Froguel, P., Zouali, H., Vionnet, N., Velho, G., Vaxillaire, M., Sun, F., Lesage, S., Stoffel, M., Takeda, J., Passa, P., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199303113281005 · Cited by 735 · cited 1×
“Most of those without diabetes have impaired fasting glucose levels”
Background
Research works printed but not linked: 1
- Pearson E et al. (2003) HDL-cholesterol: differentiating between HNF-1α MODY and type 2 diabetes [abstract]. Diabet Med 20 (Suppl 2): S1–S33
Cited by
Items 301–400 of 500
Genetic Testing in Diabetes Mellitus
Philipson, L. H., Murphy, R., Ellard, S., Hattersley, A. T., Støy, J., Greeley, S. A. W., Bell, G. I., & Polonsky, K. S. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374430-2.00002-x · Cited by 6
Self-citationJones, A. G., & Hattersley, A. T. (2010) · Wiley eBooks · doi:10.1002/9781444324808.ch15 · Cited by 10
Self-citationCurtis, D. (2021) · medRxiv · doi:10.1101/2021.01.08.21249453 · Cited by 6
Rafique, I., Mir, A., Siddiqui, S., Saqib, M. A. N., Fawwad, A., Marchand, L., Adnan, M., Naeem, M., Basit, A., & Polychronakos, C. (2021) · World Journal of Diabetes · doi:10.4239/wjd.v12.i11.1957 · Cited by 5
Mutations in MAFA and IAPP are not a common cause of monogenic diabetes
Garin, I., Martínez, R., Heras, J. D. L., Perez‐Nanclares, G., Castaño, L. A., de Nanclares, G. P., & the Spanish GEDIMO Group (2009) · Diabetic Medicine · doi:10.1111/j.1464-5491.2009.02758.x · Cited by 5
Al‐Abdulrazzaq, D., Al‐Taiar, A., Al-Haddad, M., Al-Tararwa, A., Al-Zanati, N., Al-Yousef, A., Davidsson, L., & Alkandari, H. (2021) · The Science of Diabetes Self-Management and Care · doi:10.1177/0145721721996309 · Cited by 9
“Health Literacy (HL) is defined as “the cognitive and social skills that determine the motivation and ability of individuals to gain access to, understand and use information in ways that promote and maintain good health” [1, 2].”
BackgroundSperling, M. A., & Garg, A. (2018) · Europe PMC (PubMed Central) · Cited by 10
Importance of clinical variables in the diagnosis of MODY2 and MODY3
Corrales, P. J. P., López-Garrido, M.-P., Rubio, L. L., Rodríguez, S. A., Jiménez, L. M. L., Lamas, C., García, J. J. L., Martínez, J. J. A., López, A. H., Castillo, R. R., et al. (2011) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2011.05.002 · Cited by 5
Monogenic diabetes, renal dysplasia and hypopituitarism: a patient with a HNF1A mutation
Simms, R., Sayer, J. A., Quinton, R., Walker, M., Ellard, S., & Goodship, T. H. J. (2010) · QJM · doi:10.1093/qjmed/hcq195 · Cited by 5
“Monogenic diabetes accounts for 2% of all forms of diabetes and is usually inherited in an autosomal dominant manner.(1) This prevalence is likely to rise with increasing awareness and appropriate molecular genetic testing of patients who have previously been clinically diagnosed as having type 1 or 2 diabetes.”
BackgroundSelf-citationMonogenic diabetes and type 1 diabetes mellitus: a challenging combination
Uday, S., Campbell, F., Cropper, J., & Shepherd, M. H. (2014) · Practical Diabetes · doi:10.1002/pdi.1896 · Cited by 5
MODY in Siberia – molecular genetics and clinical characteristics
Ovsyannikova, A. K., Rymar, O. D., Шахтшнейдер, Е. В., Voropaeva, E. N., Иванощук, Д. Е., & Voevoda, M. (2017) · Diabetes Mellitus · doi:10.14341/dm7920 · Cited by 7
Diagnosing monogenic diabetes: common misinterpretations of genetic findings
Rubio‐Cabezas, O. (2009) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2009.00560.x · Cited by 5
“To date, more than 20 different genetic subtypes of insulin-deficient diabetes have been identified, including autosomal (both dominant and recessive) and X-linked forms (2).”
BackgroundPregnancy and Neonatal Outcomes in Maturity-Onset Diabetes of the Young: A Systematic Review
Ługowski, F., Babińska, J., Makowska, K., Ludwin, A., & Stanirowski, P. J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26136057 · Cited by 4
Zhang, T., Hua, X., Mohindroo, C., Wang, X., Dutta, D., Liu, J., Katta, S., Li, S. A., Wang, J., Antwi, S. O., et al. (2025) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djaf308 · Cited by 5
Genome Editing and Human Pluripotent Stem Cell Technologies for in vitro Monogenic Diabetes Modeling
Dabi, Y. T., & Degechisa, S. T. (2022) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s366967 · Cited by 4
“Depending on the time of diagnosis NDM is diagnosed within the first six months of life, whereas MODY is diagnosed before the age of 25.(17)”
BackgroundMODY type diabetes: overview and recent findings
Khelifa, S. B., Barboura, I., Dandana, A., Ferchichi, S., & Miled, A. (2011) · Annales de biologie clinique · doi:10.1684/abc.2011.0605 · Cited by 5
New HNF-1α nonsense mutation causes maturity-onset diabetes of the young type 3
Nogaroto, V., Svidnicki, P. V., Bonatto, N., Milléo, F. Q., de Almeida, M. C., Vicari, M. R., & Artoni, R. F. (2011) · Clinics · doi:10.1590/s1807-59322011000100029 · Cited by 4
“The MODY 3 subtype, caused by mutations in the HNF-1a (hepatocyte nuclear factor-1 alpha) gene,(4) is the most common Mendelian form of diabetes and it is found in more than 60% of the cases classified as MODY, accounting for 1–2% of all diabetic individuals.(5) The diabetic phenotype of the carriers of this mutation…”
BackgroundFamilial diabetes of adulthood: A bin of ignorance that needs to be addressed
Prudente, S., Ludovico, O., & Trischitta, V. (2017) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2017.10.017 · Cited by 5
Diagnostik, Therapie und Verlaufskontrolle des Diabetes mellitus im Kindes- und Jugendalter
Neu, A., Bürger-Büsing, J., Danne, T., Dost, A., Holder, M., Holl, R. W., Holterhus, P., Kapellen, T. M., Karges, B., Kordonouri, O., et al. (2021) · Der Diabetologe · doi:10.1007/s11428-021-00769-1 · Cited by 5
Chen, F., Huang, J., Huang, Y. L., Chen, L., Chen, X., & Hu, J. (2015) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2015.05.026 · Cited by 3
“of diabetes and is found in more than 60% of the cases classified as MODY, accounting for 1–2% of all diabetic individuals [4].”
BackgroundRNA Sequencing of All Transcripts and How Islet β-Cells Fail
Nolan, C. J., & Delghingaro‐Augusto, V. (2014) · Diabetes · doi:10.2337/db14-0290 · Cited by 3
Cieza-Borrella, C., Díaz-Soto, G., Martínez‐Pino, I., Puig‐Domingo, M., & González‐Sarmiento, R. (2014) · Journal of Investigative Medicine · doi:10.1097/jim.0000000000000114 · Cited by 5
“Maturity-onset diabetes of the young is a hereditary subtype of nonYinsulin-dependent diabetes that represents about 1% to 2% of all diabetes cases and is associated to A-cell dysfunction.(12) There are at least 6 MODY types,(13) being the most frequent the MODY1, MODY2, and MODY3 caused by pathogenic mutations in HNF…”
BackgroundMikuscheva, A., Mekhail, A., & Wheeler, B. J. (2018) · Case Reports in Obstetrics and Gynecology · doi:10.1155/2018/9451061 · Cited by 4
Biosynthesis, Processing, and Secretion of the Islet Hormones
Steiner, D. F., Rhodes, C. J., Philipson, L. H., Bell, G. I., & Chan, S. J. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00032-0 · Cited by 4
Genetics of Diabetes and Diabetic Complications
Prasad, R. B., Ahlqvist, E., & Groop, L. (2018) · Endocrinology · doi:10.1007/978-3-319-45015-5_6 · Cited by 6
Carbohydrate Metabolism: Diabetes Mellitus, Genomic Aberrations
Semple, R. K. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.99433-9 · Cited by 4
A Review of Mouse Models of Monogenic Diabetes and ER Stress Signaling
Salpea, P., Cosentino, C., & Igoillo‐Esteve, M. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-0385-7_4 · Cited by 3
Rusyaeva, N. V., Кононенко, И. В., Vikulova, O. K., Исаков, М. А., Shestakova, M. V., & Mokrysheva, N. G. (2024) · Diabetes Mellitus · doi:10.14341/dm13100 · Cited by 3
Mazloum, A., Feoktistova, S. G., Gubaeva, A., Alsalloum, A., Mityaeva, O. N., Kim, A., Бодунова, Н. А., Woroncow, M. V., & Volchkov, P. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26168110 · Cited by 4
“However, many cases progress to insulin dependence, particularly those with severe mutations (e.g., R6C), necessitating insulin therapy within 5–10 years of diagnosis to maintain glycemic control, with only 20% of patients maintaining sulfonylurea responsiveness long-term [35].”
Ramesh, S. C., & Marshall, I. H. (2011) · The Indian Journal of Pediatrics · doi:10.1007/s12098-011-0633-4 · Cited by 3
New Insights and New Conundrums in Neonatal Hypoglycemia: Enigmas Wrapped in Mystery
Sperling, M. A. (2013) · Diabetes · doi:10.2337/db12-1839 · Cited by 3
“In addition, these insights enable rational treatments as best exemplified by the use of sulfonylureas to restore endogenous insulin secretion and ameliorate neurological impairment in neonatal diabetes caused by mutations in the ATP-sensitive K channel (KATP) channel (3).”
BackgroundNon-type 1 non-type 2 diabetes mellitus
Sukumar, N., Nair, R., & Patel, V. (2011) · The British Journal of Diabetes · doi:10.1177/1474651411417138 · Cited by 3
GCK-MODY and obesity: symptom overlap makes diagnosis difficult
Calcaterra, V., Regalbuto, C., Cave, F. D., Larizza, D., & Iafusco, D. (2020) · Acta Diabetologica · doi:10.1007/s00592-019-01473-9 · Cited by 4
Case 36-2023: A 19-Year-Old Man with Diabetes and Kidney Cysts
Vivante, A., Tan, W., Harrington, S. G., Udler, M. S., & Pollin, T. I. (2023) · New England Journal of Medicine · doi:10.1056/nejmcpc2309347 · Cited by 3
Genetics in Diabetes Mellitus - Contribution to the Classification and Management
Yu, J. (2012) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2012.17.4.211 · Cited by 3
“Difference in prognosis and treatment strongly support the use of genetic testing in the case of suspicious MODY 26, 28-43”
BackgroundInfluentialZübarioğlu, A. U., Bülbül, A., & Uslu, H. S. (2018) · SiSli Etfal Hastanesi Tip Bulteni / The Medical Bulletin of Sisli Hospital · doi:10.14744/semb.2017.51422 · Cited by 3
“Most cases of neonatal DM caused by a single gene mutation result in impaired insulin secretion.[5] Etiopathogenesis of insulin deficiency occurs via three alternative mechanisms, which consist of impairment in the development or function of beta cells or beta cell destruction (Table 1).”
BackgroundMonogenic Diabetes Mellitus: Neonatal Diabetes and Maturity-Onset Diabetes of the Young
Greeley, S. A. W., McCauley, M. K., Philipson, L. H., & Sperling, M. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-62520-3.00010-5 · Cited by 3
Fremskritt innen diabetesgenetikk
Njølstad, P. R., Hertel, J. K., Sövik, O., Ræder, H., Johansson, S., & Molven, A. (2010) · Tidsskrift for Den norske legeforening · doi:10.4045/tidsskr.09.1035 · Cited by 3
Diagnosis in diabetes: does it matter?
Thethy, I., Robertson, L., & Swaminathan, K. (2011) · The Journal of the Royal College of Physicians of Edinburgh · doi:10.4997/jrcpe.2011.205 · Cited by 3
Regulation of Insulin Secretion and Islet Cell Function
Weir, G. C., Bonner‐Weir, S., & Sharma, A. (2011) · Springer eBooks · doi:10.1007/978-1-4614-1028-7_1 · Cited by 4
Mohamed, I. M. T. N. (2014) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000332 · Cited by 3
“Permanent neonatal diabetes mellitus (PNDM) /monogenic diabetes of infancy (MDI) is a rare condition associated with defects in genes that play major roles in pancreatic beta cell development and function; mutations in the genes encoding the ATP-sensitive potassium channel (K-ATP) subunits, KCNJ11 (encoding KIR 6.2 su…”
BackgroundInfluentialMadani, H. A., Elkaffas, R. H., AlKholy, B. M., Musa, N., Shaalan, Y. M., El-Kaffas, R., Hassan, M. M., Hafez, M. M., Flanagan, S. E., Franco, E. D., et al. (2018) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-018-0658-6 · Cited by 3
“Heterozygous mutations in the KCNJ11, ABCC8, and INS genes are the most common causes of PNDM accounting for about 60% of cases [4].”
BackgroundRafique, I., Saqib, M. A. N., Fawwad, A., Zubaida, B., Naeem, M., Mir, A., & Basit, A. (2021) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-021-00926-8 · Cited by 3
“In this type, most of the mutation carriers develop this disease before 25 years of age [16].”
BackgroundMolecular genetics of monogenetic beta-cell diabetes
Sujjitjoon, J., Jungtrakoon, P., Boonyasrisawat, W., Chongjaroen, N., Chukijrungroat, T., Kooptiwut, S., Plengvidhya, N., Banchuin, N., & Yenchitsomanus, P. (2012) · Genomics and Genetics (Online) · Cited by 3
Winter, W. E., Pelletier, J. P. R., & Harris, N. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-815499-1.00034-x · Cited by 3
Diagnosis, Therapy and Follow-Up of Diabetes Mellitus in Children and Adolescents
Holder, M., Kapellen, T. M., Ziegler, R., Bürger-Büsing, J., Danne, T., Dost, A., Holl, R. W., Holterhus, P., Karges, B., Kordonouri, O., et al. (2022) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1624-3388 · Cited by 6
Genetic Risk Factors for Type 2 Diabetes and Related Traits
Hertel, J. K. (2012) · NVA (Nasjonalt vitenarkiv) · Cited by 3
Hagman, E. (2016) · Figshare · Cited by 5
WITHDRAWN: Diabetes mellitus due to toxic misfolding of proinsulin variants
Dhayalan, B., Chatterjee, D., Chen, Y., & Weiss, M. A. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101229 · Cited by 3
RetractedCharacteristics of Glycemic Variability in Patients with GCK-MODY
Ovsyannikova, A. K., Dudina, M. V., Dolinskaya, Y. A., & Rymar, O. D. (2022) · The Russian Archives of Internal Medicine · doi:10.20514/2226-6704-2022-12-6-467-472 · Cited by 2
Regenerative medicine approaches for treating diabetes: Current advances and future directions
Medenica, S., Abazović, D., Vuković, J., Vojinović, T., Tomović, F., Defeudis, G., Mazzilli, R., Kovačević, Z., Djurdjic, D., Prelević, V., et al. (2025) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2025.109232 · Cited by 5
Reddy, B. M., Zameer, N., Shruthi, P., & Archita, N. (2026) · Biosciences Biotechnology Research Asia · doi:10.13005/bbra/3484 · Cited by 2
Mohamed, S., Elkholy, S., El-Meleagy, E., Abu‐Amero, K. K., & Hellani, A. M. (2014) · Annals of Saudi Medicine · doi:10.5144/0256-4947.2014.217 · Cited by 2
The Role of Pharmacogenomics in Diabetes, HIV Infection, and Pain Management
Aquilante, C. L., & Lam, Y. W. F. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-391918-2.00007-x · Cited by 2
Maturity-Onset Diabetes of the Young Identified Among Algerian Probands with Early-Onset Diabetes
Bouldjennet, F., Gjesing, A. P., Azzouz, M., Abderrahman, S. A., Guecier, A. E., Ali, S. M., Oudjit, B., Mennadi-Lacete, F., Yargui, L., Boudiba, A., et al. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s269251 · Cited by 2
Precision Medicine in Diabetes
Dawed, A. Y., Haider, E., & Pearson, E. R. (2022) · Handbook of experimental pharmacology · doi:10.1007/164_2022_590 · Cited by 5
Diagnostik, Therapie und Verlaufskontrolle des Diabetes mellitus im Kindes- und Jugendalter
Neu, A., Bürger-Büsing, J., Danne, T., Dost, A., Holder, M., Holl, R. W., Holterhus, P., Kapellen, T. M., Karges, B., Kordonouri, O., et al. (2023) · Die Diabetologie · doi:10.1007/s11428-023-01048-x · Cited by 2
Maturity Onset Diabetes of the Young – An Overview of Common Types. A Review
Rafique, I., Saqib, M. A. N., Mir, A., & Naeem, M. (2018) · Romanian Journal of Diabetes Nutrition and Metabolic Diseases · doi:10.2478/rjdnmd-2018-0024 · Cited by 2
“The molecular diagnosis is of utmost importance as most of the time, patients were misdiagnosed as type-1 and its treatment pattern differ from type-1 diabetes [5,15].”
BackgroundCarbohydrate Metabolism, Diabetes, and Hypoglycemia
Dasgupta, A., & Wahed, A. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-407821-5.00007-3 · Cited by 2
Kshirsagar, V. Y., Ahmed, M., Colaco, S. M., Houghton, J., & Ellard, S. (2013) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-013-0153-z · Cited by 2
“Heterozygous mutations in INS accounts for 15–20 % of cases of permanent NDM [11].”
BackgroundSelf-citationLocke, J. M., Ellard, S., Norwood, V. F., & Harries, L. W. (2009) · Diabetic Medicine · doi:10.1111/j.1464-5491.2009.02705.x · Cited by 2
Self-citationMonogenic diabetes: information seeking and genetic testing access via e-mail
Shepherd, M. H. (2010) · European Diabetes Nursing · doi:10.1002/edn.157 · Cited by 2
Genetics in the Real World: Resources for Pediatric Nurses Using Monogenic Diabetes as an Exemplar
Becker, S. A., & Novak, C. K. (2011) · Journal of Pediatric Nursing · doi:10.1016/j.pedn.2011.07.005 · Cited by 2
Cost-Effectiveness of Genetic Testing for Monogenic Diabetes
Naylor, R. N., Greeley, S. A. W., & Huang, E. S. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800892-8.00027-0 · Cited by 2
Diet–Gene Interactions in the Development of Diabetes
Ordovás, J. M., Berciano, S., Micó, V., & Daimiel, L. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801585-8.00004-x · Cited by 2
Bioinformatics, Genomics and Diabetes
Sridhar, G. R., & Lakshmi, G. (2016) · SpringerBriefs in applied sciences and technology · doi:10.1007/978-981-10-0308-0_1 · Cited by 2
Biosynthesis, Processing, and Secretion of the Islet Hormones
Steiner, D. F., Rhodes, C. J., Philipson, L. H., Bell, G. I., & Chan, S. J. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00031-7 · Cited by 3
Monogenic diabetes mellitus and clinical implications of genetic diagnosis
Kang, E., Chung, L. Y., Kim, Y. J., Oh, K. E., & Rhie, Y. (2021) · Precision and Future Medicine · doi:10.23838/pfm.2021.00100 · Cited by 2
LADY and MODY: How do we know them?
Šumník, Z., & Průhová, Š. (2016) · Medicína pro praxi · doi:10.36290/med.2016.005 · Cited by 6
Emel'yanov, A. O., Sechko, E. A., Koksharova, E., Sklyanik, I. A., Кураева, Т. Л., Mayorov, A. Y., Peterkova, V. A., & Dedov, I. I. (2017) · International Medical Case Reports Journal · doi:10.2147/imcrj.s125103 · Cited by 1
Daggag, H., Gjesing, A. P., Mohammad, A., Ängquist, L. H., Shobi, B., Antony, S., Haj, D., Tikriti, A. A., Buckley, A. J., Hansen, T. F., et al. (2022) · Metabolism Open · doi:10.1016/j.metop.2022.100213 · Cited by 2
“2 ADAMTS9, SLC22A3 and MTNR1B associated with T2DM were detected [7].”
BackgroundEarly‐onset diabetes mellitus as a presenting feature of Werner's syndrome in an Indian family
Hoff, F. W., Xing, C., Simha, V., Agarwal, A. K., Zhang, X., Lekkala, L., Vaishnav, M. S., Vuitch, F., & Garg, A. (2023) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.2299 · Cited by 1
Sugano, Y., Sekiya, M., Murayama, Y., Osaki, Y., Iwasaki, H., Suzuki, H., Fukushima, H., Suzuki, H., Noguchi, E., & Shimano, H. (2025) · Diabetology International · doi:10.1007/s13340-025-00804-2 · Cited by 1
“However, we were not able to find any pathogenic mutations in either HNF1B or other genes reported to be associated with monogenic diabetes [11].”
Diabetes mellitus HNF4A-MODY in children from the Russian population: clinical and genetic features
Sechko, E. A., Лаптев, Д. Н., Koltakova, M. P., Khusainova, R. I., Minniakhmetov, I. R., Кураева, Т. Л., Eremina, I. A., Титович, Е. В., Bezlepkina, O. B., & Peterkova, V. A. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1673182 · Cited by 1
Ekwueme, D. E., Sann, K. M., & Rahman, M. M. (2025) · Cureus · doi:10.7759/cureus.96360 · Cited by 1
“Establishing the correct molecular diagnosis facilitates personalised treatment decisions and enables predictive genetic testing in relatives at risk, supporting earlier detection and intervention [7].”
Bartáková, V., Ambrožová, E., Žák, P., & Kaňková, K. (2026) · Frontiers in Physiology · doi:10.3389/fphys.2026.1778006 · Cited by 2
“…are body mass index (BMI) < 25 kg/m2 and fasting glucose ≥5.5 mmol/L, in addition to positive family medical history of diabetes and small glucose increase during oGTT, however, the definitive diagnosis requires genetic testing (Chakera et al., 2014; Ellard et al., 2000; Murphy et al., 2008).”
InfluentialMusa, N., Hafez, M. M., Hassan, M. M., El‐Mougy, F., Sharaf, S. A. E.-A., Polak, M., Cavé, H., & Mofeed, S. (2015) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-015-0431-z · Cited by 1
“NDM should have immediate molecular genetic testing to define their subtype of NDM, as type 1 diabetes (T1D) is extremely rare in this subgroup [11].”
BackgroundThe emerging landscape of childhood diabetes: unraveling the diagnosis
Amed, S., & Hamilton, J. K. (2012) · Diabetes Management · doi:10.2217/dmt.12.65 · Cited by 1
La presencia de obesidad infantil puede enmascarar el diagnóstico de diabetes monogénica
Peralta, S. R., Galán, M., Navas, M., & Guillén, L. S. (2009) · Medicina Clínica · doi:10.1016/j.medcli.2009.09.024 · Cited by 1
A pathway to insulin independence in newborns and infants with diabetes
Shahawy, S., Chan, N. K., Ellard, S., Young, E., Shahawy, H. E., Mace, J., Peverini, R. L., Chinnock, R., Njølstad, P. R., Hattersley, A. T., et al. (2011) · Journal of Perinatology · doi:10.1038/jp.2011.4 · Cited by 1
Self-citationAutoantibodies and type 1 diabetes: are we still in the cave of an ancient myth?
Galderisi, A. (2014) · Diabetologia · doi:10.1007/s00125-014-3261-5 · Cited by 1
Genetically Programmed Defects in β-Cell Function
Pal, A., & Gloyn, A. L. (2011) · Springer eBooks · doi:10.1007/978-1-4419-6956-9_13 · Cited by 1
Solano, E. B., Madrigal, E. B., Francisco, Y. P., Sosa, R. P., García, Á. B., Iglesia, Á. G., & Chávez, J. G. (2013) · Revista cubana de endocrinología · Cited by 1
Onyiriuka, A. N., & Ofoeze, C. A. (2015) · Aristotle University Medical journal/Aristotle University Medical Journal · Cited by 1
Monogenic diabetes: could this be your patient?
Murphy, A. (2017) · Independent Nurse · doi:10.12968/indn.2017.5.17 · Cited by 1
Hegde, P., Meldon, A., Lamen, L., Sharma, D., & Kalathil, D. (2017) · Practical Diabetes · doi:10.1002/pdi.2145 · Cited by 1
The Role of Monogenic Diabetes in Pediatric Type 2 Diabetes
Tucker, S. E., Philipson, L. H., & Naylor, R. N. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-55138-0.00005-x · Cited by 2
Management of Diabetes Mellitus in Children
Wolfsdorf, J. I., & Botero, D. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00049-6 · Cited by 1
Diagnosis of MODY - brief overview for clinical practice
Urbanová, J., Brunerová, L., & Brož, J. (2018) · Vnitřní lékařství · doi:10.36290/vnl.2018.054 · Cited by 2
Wolfsdorf, J. I., & Sperling, M. A. (2012) · Springer eBooks · doi:10.1007/978-3-642-02202-9_387 · Cited by 1
Endokrinologische Indikationen zur Gendiagnostik
Schäffler, A., Bollheimer, C., Büttner, R., Girlich, C., Aslanidis, C., Dietmaier, W., Bala, M., Guralnik, V., Karrasch, T., & Schneider, S. (2018) · Springer eBooks · doi:10.1007/978-3-662-55914-7_15 · Cited by 1
A Practical Approach to the Diagnosis of Type 1 Diabetes: An Indian Perspective
Kumaran, S., Lalvani, N., Jevalikar, G., Sarda, A., & Unnikrishnan, A. G. (2023) · Chronicle of Diabetes Research and Practice · doi:10.4103/cdrp.cdrp_19_22 · Cited by 1
Fay, E., Simmons, L. E., & BROWN, C. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-82823-9.00008-8 · Cited by 1
Robino, A., Tornese, G., Tinti, D., Dovč, K., Castorani, V., Conti, A., Franceschi, R., Rabbone, I., Bonfanti, R., Battelino, T., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11071951 · Cited by 1
Decoding MODY: exploring genetic roots and clinical pathways
Phadnis, A., Chawla, D., Alex, J., & Jha, P. (2025) · Diabetology International · doi:10.1007/s13340-025-00809-x · Cited by 2
Demander un diagnostic génétique en diabétologie
Bellanné‐Chantelot, C., Saint‐Martin, C., & Ciangura, C. (2011) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(11)70298-x · Cited by 1
Genetics of Type 2 Diabetes: From Candidate Genes to Genome-Wide Association Analysis
Brown, K. M., & Shuldiner, A. R. (2009) · Springer eBooks · doi:10.1007/978-0-387-09841-8_10 · Cited by 1
Intrafamilial Variability of Early-Onset Diabetes due to anINSMutation
Fredheim, S., Svensson, J., Pörksen, S., Hansen, L., Hansen, T. F., Pedersen, O. B., Mortensen, H. B., Barbetti, F., & Nielsen, L. B. (2011) · Case Reports in Genetics · doi:10.1155/2011/258978 · Cited by 1
Quand et pourquoi rechercher un diabète monogénique ?
Timsit, J., Carette, C., Saint‐Martin, C., Dubois‐Laforgue, D., & Bellanné‐Chantelot, C. (2009) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(09)72415-0 · Cited by 1
Monogenic diabetes and the role of the diabetes nurse
Shepherd, M. H. (2014) · European Diabetes Nursing · doi:10.1002/edn.242 · Cited by 1
Metadata
- Authors
- Murphy, R., Ellard, S., & Hattersley, A. T.
- Affiliations
- University of Exeter (GB)
- Corresponding author
- Hattersley, Andrew T
- Venue
- Nature Clinical Practice Endocrinology & Metabolism
- Published
- 2008-02-26
- Volume
- 4
- Issue
- 4
- Pages
- 200-213
- ISSN
- 1745-8366 (ISSN-L)
- 1745-8374
- OpenAlex
- W1996549380
- Semantic Scholar
- ca1487d43edc4a5abbe40904a2e6414a4534638e
- Cited by
- 502
- References
- 91
- Citations by year
- 2026: 6 · 2025: 14 · 2024: 10 · 2023: 18 · 2022: 17 · 2021: 33 · 2020: 23 · 2019: 21 · 2018: 34 · 2017: 32 · 2016: 33 · 2015: 33 · 2014: 36 · 2013: 29 · 2012: 42
- FWCI
- 6.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Clinical Practice Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- ResearchSpace (University of Auckland) (submittedVersion)
- Funders
- Wellcome Trust
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- monogenic diabetes, maturity-onset diabetes of the young, neonatal diabetes, molecular genetic classification, Kir6.2, SUR1, sulfonylurea therapy, glucokinase mutations, HNF1A, HNF4α, HNF1B, genetic counseling, insulin therapy
- MeSH terms
- Kcnj11 Channel, Diabetes Mellitus, Diagnosis, Differential, Female, Glucokinase, Humans, Infant, Newborn, Male, Mutation, Receptors, Drug, Potassium Channels, ATP-Binding Cassette Transporters, Potassium Channels, Inwardly Rectifying, Insulin-Secreting Cells, Hepatocyte Nuclear Factor 1-alpha, Hepatocyte Nuclear Factor 4, Sulfonylurea Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.